NPPB and hydrops fetalis: While measurement of natriuretic peptides for the diagnosis of HF has been a major landmark in cardiology [5], diagnostic utility of peptides such as N-terminal pro-B-type natriuretic peptide (NT-proBNP) as biomarkers for HF in ESRD patients is strongly reduced [6].